Medicine & Life Sciences
Prostatic Neoplasms
100%
Castration
57%
Breast Neoplasms
36%
Docetaxel
26%
Neoplasms
25%
Cell-Free Nucleic Acids
25%
abiraterone
21%
Androgen Receptors
21%
Therapeutics
20%
Survival
19%
Abiraterone Acetate
18%
Renal Cell Carcinoma
18%
Androgens
17%
Drug Therapy
16%
Trastuzumab
15%
Irinotecan
14%
Prostate-Specific Antigen
13%
Progression-Free Survival
12%
Prednisone
11%
Neoplasm Metastasis
11%
Urinary Bladder Neoplasms
10%
Plasma Cells
10%
big gastrin
10%
Liquid Biopsy
9%
Hormones
9%
Quality of Life
8%
Recurrence
8%
pembrolizumab
8%
Circulating Neoplastic Cells
8%
Chromogranin A
8%
Safety
7%
Cachexia
7%
Circulating Tumor DNA
7%
Organized Financing
7%
Genes
7%
Manuscripts
7%
Confidence Intervals
6%
Breast
6%
Mammography
6%
atezolizumab
6%
Serum
6%
Fatigue
6%
ixabepilone
6%
Radium-223
6%
pixantrone
6%
Guidelines
5%
Biomarkers
5%
Carcinoma
5%
dolastatin 10
5%
human ERBB2 protein
5%